Table 2.

Treatment and outcomes.

Outcome	N	Mean	95%CI
Treatment duration (years)	355	2.57	2.44−2.72
CA at treatment end (years)	358	10.03	9.93−10.14
BA at treatment end (years)	303	11.67	11.58−11.76
BMI at treatment end (SDS)	357	1.06	0.93−1.20
Height at treatment end (cm)	357	144.7	143.94−145.46
Height at treatment end of (SDS)	357	1.31	1.18−1.442
Age at menarche (years)	272	11.23	11.10–11.368
Age at AH	216	13.54	13.30-13.77
Time from treatment end to menarche (months)	271	14.00	12.76−15.23
AH (cm)	216	157.3	156.3−158.29
AH (SDS)	216	0.57	0.384−0.749
AH – TH (cm)	216	-1.51	-2.56− -0.45
AH – TH (SDS)	216	0.89	0.72−1.06
AH – PAH (cm)	207	-2.57	-3.56− -1.58
AH - height at treatment end (cm)	209	12.08	11.45−12.7
AH - height at treatment end (SDS)	209	-0.76	-0.91 – -0.61
BMI at AH (SDS)	201	0.93	0.74−1.11

CA, chronological age; BA, bone age; BMI, body mass index; AH, adult height; TH, target height; PAH, predicted adult height.